Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab. Appleton L, Day AS. Aliment Pharmacol Ther 2020;52:1080-1081.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Appleton L, Day AS. Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab. Aliment Pharmacol Ther 2020;52:1080-1081.
PMID: 33119166